Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities Grid The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015)
The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.
All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.
The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.
Activity Title: 2019 National Conference & Exhibition Activity Location: New Orleans, LA Activity Dates: 10/25/2019 – 10/29/2019
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Abrams, Steven Faculty Yes Milk Processors Educational Program: Paid Consultant
I do not intend to discuss
Abzug, Joshua Faculty, Moderator
Yes Springer: Royalties I do not intend to discuss
Agarwal, Rita Faculty No None I do intend to discuss
Agus, Michael Faculty No None I do intend to discuss
Ajayi, Akinyemi Faculty Yes Jazz Pharmaceuticals: Paid Consultant; Speakers' Bureau
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Albanese, Stephen Faculty No None I do intend to discuss
Alverson, Dale Faculty Yes Welcome Home Health: Paid Consultant GlobalMed: Paid Consultant Vision Quest: Paid Consultant
I do not intend to discuss
Balistreri, William Faculty Yes Gilead Sciences: Research Grant Merck: Research Grant AbbVie: Research Grant Alexion Pharma GmbH: Scientific Advisory Board Digestive Care: Consultant Kadmon Pharmaceuticals, LLC: Advisory Board Otsuka: Consultant
I do not intend to discuss
Barnert, Elizabeth Faculty No None I do intend to discuss
Barnett, Elizabeth Faculty Yes PaxVax: Research Grant Wolters Kluwer: Royalties AAP: Royalties BMJ Best Practice: Honorarium
I do intend to discuss
Berman, Suzanne Faculty, Moderator
Yes Connexin Software: Paid Consultant Script Doctor LLC: Employee
I do not intend to discuss
Betancourt, Theresa Faculty No None I do intend to discuss
Biondi, Eric AAP Section/Council Abstract Chair
Yes McKesson Inc: Paid Consultant I do not intend to discuss
Bree, Alanna Faculty No None I do intend to discuss
Breuner, Cora Faculty No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Brooks, Lee AAP Section/Council Program Chair
Yes Merrill Lynch: Stocks/Bonds Abbvie: Stocks/Bonds Saepta: Stocks/Bonds Cardinal Health: Stocks/Bonds LabCorp: Stocks/Bonds Novartis: Stocks/Bonds CVS: Stocks/Bonds Teva: Stocks/Bonds Pfizer: Stocks/Bonds Roche: Stocks/Bonds GlaxoSmith Kline (GSK): Stocks/Bonds Sanofi: Stocks/Bonds Merck: Stocks/Bonds Johnson & Johnson: Stocks/Bonds Bristol Myers: Stocks/Bonds Henry Schein: Stocks/Bonds Bausch Health: Stocks/Bonds Coca-Cola: Stocks/Bonds Pepsi Co.: Stocks/Bonds
I do not intend to discuss
Brothers, Kyle Moderator No None I do intend to discuss
Bucci-Rechtweg, Christina
AAP Section/Council Program Chair
Yes Novartis Pharmaceuticals Corporation: Employee; Shareholder
I do not intend to discuss
Bulas, Dorothy Faculty No None I do intend to discuss
Burstein, Gale Planning Group Member
Yes Allergan Pharma: Speakers' Bureau - Spouse/Partner I do not intend to discuss
Cain, Kathleen Faculty Yes Main Street Vaccines: Employee I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Campbell, James Faculty Yes Merck: Research Grant Sanofi: Research Grant GSK: Research Grant Sanaria: Data Safety Monitoring Board
I do intend to discuss
Chaffee, Tonya Faculty Yes Merck Inc: Trainer Hologic: Paid Consultant
I do not intend to discuss
Chan, Yee-Ming Faculty Yes Endo Pharmaceuticals: Paid Consultant I do intend to discuss
Chang, Todd Faculty Yes SBC Med Sim, LLC: Independent Contractor Oculus from FaceBook: Research Grant
I do not intend to discuss
Corcoran, Julia Faculty Yes Immersive Touch, Inc: Stocks/Bonds I do not intend to discuss
Cosgrove, Lisa Moderator Yes Teladoc: Stocks/Bonds Spouse I do not intend to discuss
Dahl-Grove, Deanna Faculty No None I do intend to discuss
Danielpour, Lisa Faculty Yes Allscripts: Honorarium I do not intend to discuss
de Souza, Luciara Faculty Yes Cerner Corporation: Employee I do not intend to discuss
Devarajan, Prasad Faculty Yes BioPorto Inc: Licensing Agreement on Patents I do not intend to discuss
Di Lorenzo, Carlo Faculty Yes Mahana: Paid Consultant QOL: Paid Consultant Shire: Paid Consultant Allergan: Paid Consultant
I do intend to discuss
Dietert, Rodney Faculty Yes Seed: Paid Consultant I do not intend to discuss
Eneli, Ihuoma Faculty Yes Rhythm Pharmaceuticals: Research Grant I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Espinosa, Claudia AAP Section/Council Program Chair
Yes AstraZeneca: Speakers' Bureau Gilead: Research Grant Nabriva: Research Grant Durata Therapeutic: Research Grant Allergan: Research Grant The Medicine Company: Research Grant Merck: Research Grant PRA Health Sciences: Reserach Grant
I do not intend to discuss
Fanaroff, Jonathan Faculty Yes Monogram Orthopaedics, Inc.: Investor I do not intend to discuss
Fisher, Margaret Faculty No None I do intend to discuss
Fleegler, Eric Faculty Yes Veta Health: Paid Consultant Wolters Kluwer: Royalties Springer Nature: Editor Fee
I do not intend to discuss
Flynn, Joseph Faculty Yes Silvergate Pharmaceuticals: Paid Consultant Ultragenyx, Inc: Data and Safety Monitoring Board Springer: Royalties Wolters Kluwer: Royalties NIDDK: Research Grant American Heart Association: Research Grant
I do not intend to discuss
Fogel, Mark Moderator No None I do intend to discuss
Forkey, Heather Faculty No Precision Optics Corporation: Employee (Spouse) I do not intend to discuss
Foulds, Michael Planning Group Member
No None I do intend to discuss
Freed, Michael Faculty No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Frenck, Robert AAP Section/Council Program Chair
Yes Merck: Research Grant Pfizer: Research Grant GSK: Research Grant
I do not intend to discuss
Gargiulo, Dominic Teaching Assistant
No None I do intend to discuss
Gerardin, Jennifer AAP Section/Council Abstract Chair
No None I do intend to discuss
Ghali, Fred Faculty Yes Galderma Labs, USA: Speakers' Bureau Ortho Dermatologics: Speakers' Bureau Proctor & Gamble: Honorarium Advisory Board Pierre-Fabre: Speakers' Bureau Promius Pharmaceuticals: Speakers' Bureau Sanofi-Regeneron: Speakers' Bureau Verrica Pharmaceuticals: Honorarium Advisory Board Leo Pharmaceuticals: Research Grant Top MD, Inc.: Stocks/Bonds Pfizer: Honorarium Cutanea Pharmaceuticals: Honorarium
I do intend to discuss
Gillette, Meredith Faculty Yes Novo Nordisk: Paid Consultant I do not intend to discuss
Gleason, Mary Margaret Faculty Yes William Josef Foundation, Institute of Mental Hygiene: Program Funding
I do not intend to discuss
Green, Andrea Faculty No None I do intend to discuss
Greenberg, Katherine Faculty Yes Merck: Speakers' Bureau I do intend to discuss
Griffiths, Anne Faculty Yes Vertex Pharmaceuticals, INC: Research Grant Parion Sciences, INC: Research Grant
I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Hamele, Mitchell Faculty Yes US, Department of Defense: Employee I do not intend to discuss
Hart, Chip Faculty Yes PCC: Employee PedsOne: Minority Owner
I do not intend to discuss
Hassink, Sandra Planning Group Member
Yes Weight Watchers: Honorarium I do not intend to discuss
Hays, Stephen Faculty No None I do intend to discuss
Hiramatsu, Mika Planning Group Member
Yes Abbott Labs: Stocks/Bonds Agilent Tech: Stocks/Bonds Baxter Intl: Stocks/Bonds Brooks Automation: Stocks/Bonds Entegris Inc: Stocks/Bonds Royal Philips Electronics Co LTD: Stocks/Bonds Kyocera Corp: Stocks/Bonds Panasonic Corp: Stocks/Bonds Shire PLC: Stocks/Bonds RTI Surgical Inc: Stocks/Bonds Varian Medical Systems, Inc.: Stocks/Bonds Varex Imaging Corporation: Stocks/Bonds
I do not intend to discuss
Hogan, Angela Faculty Yes GSK: Speakers' Bureau I do not intend to discuss
Hornik, Christoph Faculty No None I do intend to discuss
Hubbard, Dena Faculty, Moderator
Yes Abbott Nutrition: Speakers' Bureau I do not intend to discuss
Hunt, Reagan Faculty Yes Wolters Kluwer: Royalties Medscape, LLC: Royalties Dermavant: Paid Consultant
I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Inge, Thomas Faculty Yes Standard Bariatrics: Honorarium Wolters Kluwer: Honorarium Independent Medical Expert Consulting Services: Honorarium
I do not intend to discuss
Kadom, Nadja Faculty No None I do intend to discuss
Kang, Peter Faculty Yes AveXis: Paid Consultant ChromaDex: Paid Consultant Sarepta Therapeutics: Paid Consultant Springer: Co-editor Wiley: Associate Editor Wolters Kluwer: Author
I do intend to discuss
Kaye, David Faculty Yes Pfizer: Clinical Trial Health Now/BlueCross BlueShield: QI Committee
I do not intend to discuss
Keeshin, Brooks Faculty Yes Wolters Kluwer: Royalties Hunter College: Paid Consultant SAMHSA: Research Grant Uppsala University: Research Grant
I do not intend to discuss
Kim, Jae Faculty Yes Medela: Paid Consultant Mead Johnson: Speakers' Bureau Abbott Nutrition: Speakers' Bureau Ferring: Paid Consultant Mallinckrodt: Research Grant Pediasolutions: Stocks/Bonds Nicolette: Stocks/Bonds Astarte: Stocks/Bonds Evolve: Paid Consultant Alcresta: Paid Consultant Astarte: Paid Consultant
I do not intend to discuss
Kimberlin, David Faculty Yes Novavax: Research Grant I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Kirkendall, Eric AAP Section/Council Abstract Chair
Yes Vigilanxz: Royalties I do not intend to discuss
Kressly, Susan Faculty Yes Connexin Software: Employee (Self & Spouse/Partner) Pediatric Management Institute: Paid Consultant AccuVax: Paid Consultant
I do not intend to discuss
Krugman, Scott AAP Section/Council Program Chair
No None I do intend to discuss
Kundu, Anjana Faculty No None I do intend to discuss
Kuriakose, Kevin Faculty No None I do intend to discuss
Lam, Wilbur Moderator Yes Sanguina LLC: Stocks/Bonds I do intend to discuss
Lee, Lois Faculty Yes Wolters Kluwer: Royalties I do not intend to discuss
Logan, Kelsey Faculty, AAP Section/Council Program Chair
No None I do intend to discuss
Long, Justin Faculty No None I do intend to discuss
Madden, Susanne Faculty Yes Verden Group: Shareholder Patient Centered Solutions: Shareholder National Breastfeeding Center: Shareholder Independent Practice MSO: Shareholder
I do not intend to discuss
Mahle, William Faculty No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Maisels, Jeffrey Faculty Yes Draeger Medical: Paid Consultant Capnia: Paid Consultant
I do not intend to discuss
Majumdar, Indrajit Faculty Yes Rhythm Pharmaceuticals: Clinical Trial Novo Nordisk: Clinical Trial OPKO Health: Clinical Trial Pfizer: Clinical Trial
I do not intend to discuss
Mauch, Teri Faculty Yes Alexion Pharmaceuticals: Research Grant I do not intend to discuss
McColley, Susanna Faculty, AAP Section/Council Program Chair
Yes Vertex Pharmaceuticals, Inc: Paid Consultant; Speakers' Bureau
I do not intend to discuss
Mears, Cynthia Faculty Yes Pfizer: Speakers' Bureau I do not intend to discuss
Melwani, Anjna Faculty No None I do intend to discuss
Messacar, Kevin Faculty Yes National Institute of Allergy and Infectious Diseases: Research Grant
I do intend to discuss
Minich, L. LuAnn Moderator No None I do intend to discuss
Mistovich, Ronald Moderator Yes Orthopediatrics: Paid Consultant Right Mechanics: Stocks/Bonds
I do not intend to discuss
Nataro, James Faculty Yes Innovate: Paid Consultant I do not intend to discuss
Neu, Josef Faculty Yes Infant Bacterial Therapeutics: Research Grant I do not intend to discuss
Newland, Jason Faculty Yes Merck: Research Grant Allergan: Clinical Trial
I do not intend to discuss
Ngo, Thuy AAP Section/Council Program Chair
Yes Welch Allyn: Paid Consultant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Nurko, Samuel Faculty Yes Allergan inc: Research Grant Sucampo Pharmaceutica: Honorarium (Consultant)
I do not intend to discuss
Oakley, Christopher Faculty No None I do intend to discuss
O'Connor, Mary Faculty No None I do intend to discuss
Otsuka, Norman Faculty Yes Journal of the American Academy of Orthopaedic Surgeons: Paid Consultant
I do not intend to discuss
Palmer, Blake Faculty Yes Astellas: Research Grant I do not intend to discuss
Parker, Margaret AAP Section/Council Program Chair
No None I do intend to discuss
Parnes, Mered Faculty Yes Kadmon Corporation: Honorarium PTC Therapeutics: Honorarium Teva Pharmaceutical Industries Ltd: Paid Consultant Medlink: Royalties
I do intend to discuss
Parsi, Linda Faculty Yes Parsi Pediatrics: Owner The P.E.D.S. MD Company: Owner
I do not intend to discuss
Parsons, Julie Faculty Yes Biogen: Research Grant; Honorarium AveXis: Research Grant; Honorarium Scholar Rock: Research Grant PTC Therapeutics: Research Grant
I do intend to discuss
Partap, Sonia Faculty No None I do intend to discuss
Pasternak, Ryan Faculty No None I do intend to discuss
Patel, Aloka Faculty Yes Mead Johnson Nutrition: Research Grant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Peltier, Christopher Faculty, Moderator
Yes Mead Johnson: Speakers' Bureau Merck: Research Grant GSK: Research Grant Sanofi: Research Grant BBN Nutrition: Research Grant
I do not intend to discuss
Petersen, Brett Faculty No None I do intend to discuss
Pitt, Michael Faculty No None I do intend to discuss
Prudent, Joshua AAP Section/Council Abstract Chair
No None I do intend to discuss
Puttgen, Katherine Faculty No None I do intend to discuss
Radesky, Jenny Faculty Yes Public Broadcasting Service: Paid Writer Melissa & Doug Toys: Paid Consultant
I do not intend to discuss
Rager, Kristin Faculty No None I do intend to discuss
Reber, Kristina Moderator Yes Procter and Gamble: Stocks/Bonds (Spouse) Children's Hospital Neonatal Consortium: Executive Board
I do not intend to discuss
Reynolds, Jason Faculty No None I do intend to discuss
Riccio, Anthony Faculty Yes Elsevier: Royalties I do not intend to discuss
Rios, Angel AAP Section/Council Program Chair
No None I do intend to discuss
Ross, Lainie Faculty Yes GE: Stocks/Bonds Bristol Meyers Squibb: Stocks/Bonds
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Rouce, Rayne Faculty Yes Novartis Pharmaceuticals: Honorarium KITE/Gilead Pharma: Honorarium TESSA Pharmaceuticals: Research Grant
I do intend to discuss
Rowe, Peter Faculty No None I do intend to discuss
Rowley, Anne Heitzman Planning Group Member
Yes Wolters Kluwer: Paid Consultant I do not intend to discuss
Rush, Eric Faculty Yes Alexion Pharmaceuticals: Speakers' Bureau Ultragenyx Pharmaceuticals: Speakers' Bureau Biomarin Pharmaceuticals: Paid Consultant Abeona Therapeutics: Stocks/Bonds Affimed NV: Stocks/Bonds Amarin Corp PC: Stocks/Bonds Array Biopharma: Stocks/Bonds Aveo Pharmaceuticals: Stocks/Bonds Bristol Meyers Squibb: Stocks/Bonds Celgene Inc: Stocks/Bonds Clovis Oncology: Stocks/Bonds Deciphera Pharmaceuticals: Stocks/Bonds Genmab AS: Stocks/Bonds Halozyme Therapeutics: Stocks/Bonds Intercept Pharmaceuticals: Stocks/Bonds Kala Pharmaceuticals: Stocks/Bonds Portola Pharmaceuticals: Stocks/Bonds Scynexis Inc: Stocks/Bonds Seattle Genetics: Stocks/Bonds Spectrum Pharmaceuticals: Stocks/Bonds Trillium Therapeutics: Stocks/Bonds VolitionRx: Stocks/Bonds
I do not intend to discuss
Sandel, Megan Faculty Yes Enterprise Community Partners: Board of Trustees I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Schechter, Michael Faculty Yes Abbvie: Paid Consultant; Speakers' Bureau Novartis: Research Grant Translate Bio: Research Grant
I do not intend to discuss
Scherl, Susan Faculty Yes Wolters Kluwer: Royalties Lippincott/Wolters Kluwer: Royalties
I do not intend to discuss
Scholer, Seth Faculty Yes Play Nicely Program: Royalties I do not intend to discuss
Schonwald, Alison Faculty No None I do intend to discuss
Sectish, Theodore Faculty Yes I-PASS Patient Safety Institute: Paid Consultant (Spouse)
I do not intend to discuss
Shah, Binita Faculty Yes McGraw-Hill Co: Royalties, Research Grant Symposia Medicus: Honorarium
I do not intend to discuss
Shelov, Eric AAP Section/Council Program Chair
No None I do intend to discuss
Shu, Jennifer Planning Group Member
Yes AAP: Royalties I do not intend to discuss
Sicherer, Scott Faculty Yes HAL Allergy: Research Grant I do intend to discuss
Silver, Alyssa Faculty No None I do intend to discuss
Slusher, Tina Faculty No None I do intend to discuss
Smith, P. Brian AAP Section/Council Program Chair
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Sohl, Kristin Faculty Yes Autism Navigator/Florida State University: Paid Consultant Autism Speaks: Research Grant HRSA/MCHB: Research Grant Quadrant Biosciences: Honorarium; Research Grant Missouri Department of Mental Health: State Contract University of New Mexico: Paid Consultant
I do not intend to discuss
Song, Clara AAP Section/Council Abstract Chair
Yes Mead Johnson Nutrition: Speakers' Bureau I do not intend to discuss
Spector, Nancy Faculty, Moderator
Yes I-PASS Patient Safety Institute: Founder PCCORI: Research Grant
I do not intend to discuss
Starke, Jeffrey Faculty Yes Otsuka Pharmaceuticals: Data Safety Monitoring Board
I do not intend to discuss
Stricker, Paul Faculty Yes The Juice Plus Company: Paid Health Advisory Board Consultant
I do not intend to discuss
Suchdev, Parminder Faculty No None I do intend to discuss
Suh, Donny Faculty Yes National Institute of Health: Investigator I do not intend to discuss
Sweeney, Brooke Faculty No None I do intend to discuss
Tan, Tina Faculty Yes Sanofi Pasteur: Research Grant Merck: Research Grant Pfizer: Research Grant DMID: Data Safety Monitoring Committee ILiAd Biotechnologies: DMSB
I do not intend to discuss
Tandon, Animesh Moderator Yes Synergen Tech Labs: Research Grant VARYFII Imagining: Stocks/Bonds
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Teitelbaum, Jonathan Planning Group Member
Yes Wolters Kluwer: Royalties I do not intend to discuss
Theos, Amy Faculty No None I do intend to discuss
Thilo, Elizabeth Faculty No None I do intend to discuss
Tridas, Eric Faculty Yes Tris Pharma: Speakers' Bureau; Paid Consultant Shire: Paid Consultant
I do not intend to discuss
Twombley, Katherine Planning Group Member
Yes Novartis: Research Grant Kaneka: Research Grant
I do not intend to discuss
Velez-Yanguas, Maria Faculty Yes NovoNordisk: Paid Consultant Octapharma: Paid Consultant
I do not intend to discuss
Vogel, Tiphanie Faculty No None I do intend to discuss
Wang, Julie AAP Section/Council Program Chair
Yes DBV Technologies: Paid Consultant ALK Abello: Paid Consultant
I do not intend to discuss
Weems, Mark Faculty Yes Abbott: Paid Consultant I do not intend to discuss
Weiner, Gary Faculty No None I do intend to discuss
Wexelblatt, Scott Faculty Yes Abbott Nutrition: Speakers' Bureau I do not intend to discuss
White, Robert Faculty Yes Philips: Paid Consultant Natus: Paid Consultant Mednax: Employee
I do not intend to discuss
Whitehead, Ralph Faculty No None I do intend to discuss
Winter, Jameel Teaching Assistant
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Witchel, Selma F. Faculty No None I do intend to discuss
Wolraich, Mark Faculty No None I do intend to discuss
Wolynn, Todd Planning Group Member
Yes Merck: Paid Consultant Sanofi: Speakers' Bureau National Breastfeeding Center: Employee Kids Plus Pediatrics: Employee
I do not intend to discuss
Wusthoff, Courtney Faculty Yes Ceribell: Paid Consultant I do not intend to discuss
Yen, Yi-Meng AAP Section/Council Abstract Chair
Yes Smith-Nephew: Paid Consultant Orthopediatrics: Paid Consultant
I do not intend to discuss
Zempsky, William Faculty Yes Glaxo Smith Kline: Paid Consultant Pfizer: Paid Consultant Endo Pharmaceuticals: Data Safety Monitoring Board Vapogenix: Scientific Advisory Board
I do not intend to discuss
Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities Grid The AAP CME/CPD program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME/CPD program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families. (AAP CME/CPD Program Mission Statement, May 2015)
The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.
All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.
The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.
Activity Title: 2019 National Conference & Exhibition Activity Location: New Orleans, LA Activity Dates: 10/25/2019 – 10/29/2019
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Ackerman, Michael Abstract Reviewer
Yes AliveCor: Royalties Audentes Therapeutics: Consultant Blue Ox Health: Potential royalties Boston Scientific: Consultant Gilead Sciences: Consultant Invitae: Consultant Medtronic: Consultant MyoKardia: Consultant St. Jude Medical: Consultant StemoniX: Royalties
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Afzal, Bushra Co-Author, Senior Author
No None I do intend to discuss
Alfath, Zineb Co-Author No None I do intend to discuss
Anderson, Patricia Senior Author, Co-Author
Yes Bryn Pharma: Consultant I do not intend to discuss
Andras, Lindsay Presenting Author, Co-Author
Yes Biomet: Consultant; Speaker Eli Lilly: Stocks/Bonds Journal of Pediatric Orthopedics: Editorial or Governing Board Medtronic: Consultant; Speaker NuVasive: Consultant; Speaker's Bureau Orthobullets: Publishing Royalties; Financial or Material Support Pediatric Orthopaedic Society of North America: Board/Committee Member Scoliosis Research Society: Board/Committee Member Zimmer: Consultant
I do not intend to discuss
Aouthmany, Moustafa Abstract Reviewer
Yes Abbott Nutrition: Neonatology Advisory I do not intend to discuss
Arkader, Alexandre Senior Author, Co-Author
Yes Clementia: Consultant Orthofix: Consultant; Speaker's Bureau Orthopediatrics: Consultant; Speaker's Bureau
I do not intend to discuss
Armstrong, Sarah Abstract Reviewer
Yes AstraZeneca: Research Grant Rhythm Pharmaceuticals: Speaker's Bureau
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Atanda, Alfred Co-Author, Senior Author
Yes Center for Advanced Orthopedics: Consultant Community E-consult Network: Consultant GW Medical Associates: Consultant XpertCare: Consultant
I do not intend to discuss
Axelrod, David Co-Author Yes Lighthaus Inc: Stocks/Bonds I do not intend to discuss
Babl, Franz E Senior Author No None I do intend to discuss
Bailey, Michael Co-Author Yes Scioto Biosciences: Stocks/Bonds I do not intend to discuss
Bakker, Jill Co-Author No None I do intend to discuss
Banerjee, Ritu Presenting Author, Co-Author
Yes Accelerate Diagnostics: Research Grant BioFire: Research Grant Biomerieux: Research Grant Roche: Research Grant
I do not intend to discuss
Bansal, Ashish Co-Author Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds
I do not intend to discuss
Baselga, Eulalia Presenting Author, Senior Author
Yes Pierre Fabre: Consultant I do not intend to discuss
Bass, Alice Co-Author No None I do intend to discuss
Becken, Bradford Presenting Author, Co-Author
No None I do intend to discuss
Beers, Nathaniel Abstract Reviewer
Yes Amazon: Stocks/Bonds Apple: Stocks/Bonds General Mills: Stocks/Bonds IBM: Stocks/Bonds
I do not intend to discuss
Bergonzelli, Gabriela Co-Author Yes Nestle: Employee I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Besner, Gail Presenting Author, Co-Author, Senior Author
Yes Scioto Biosciences: Consultant; Research Grant; Stocks/Bonds
I do not intend to discuss
Bhakta, Hemangini Co-Author, Presenting Author
No None I do intend to discuss
Bhatia, Amina Senior Author, Co-Author
No None I do intend to discuss
Biko, David Presenting Author, Co-Author
No None I do intend to discuss
Biondi, Eric Abstract Reviewer
Yes McKesson Inc: Consultant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Blauvelt, Andrew Co-Author Yes Abbvie: Consultant; Research Grant Aclaris: Consultant; Research Grant Allergan: Consultant; Research Grant Almirall: Consultant; Research Grant Amgen: Consultant; Research Grant Boehringer-Ingelheim: Consultant; Research Grant Celgene: Consultant; Research Grant Dermavant: Consultant; Research Grant Dermira: Consultant; Research Grant Eli Lilly: Consultant; Research Grant; Speaker's Bureau Genentech/Roche: Consultant; Research Grant GlaxoSmithKline: Consultant; Research Grant Janssen: Consultant; Research Grant; Speaker's Bureau LEO Pharma: Consultant; Research Grant Merck: Consultant; Research Grant Novartis: Consultant; Research Grant Pfizer: Consultant; Research Grant Purdue Pharma: Consultant; Research Grant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Speaker's Bureau Sandoz: Consultant; Research Grant Sanofi Genzyme: Consultant; Research Grant; Speaker's Bureau Sienna Pharmaceuticals: Consultant; Research Grant Sun Pharma: Consultant; Research Grant UCB: Consultant; Research Grant Valeant Pharmaceutical Co: Consultant; Research Grant Vidac: Consultant; Research Grant
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Boguniewicz, Mark Co-Author Yes Eli Lilly: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Speaker's Bureau Sanofi: Consultant; Research Grant; Speaker's Bureau
I do not intend to discuss
Bouchillon, Samuel Co-Author, Presenting Author
Yes International Health Management Associates, Inc: Consultant
I do not intend to discuss
Bresnahan, Brian Co-Author Yes Bill and Melinda Gates Foundation: Research Grant Johnson & Johnson: Stocks/Bonds University of Washington Medical Center and Harborview Medical Center: Employee; Research Grant
I do intend to discuss
Brown, Heather Co-Author Yes Evolve Biosystems: Employee I do not intend to discuss
Brown, Lou Ann Co-Author No None I do intend to discuss
Bucci-Rechtweg, Christina
Abstract Reviewer
Yes Novartis Pharmaceuticals: Employee; Stocks/Bonds I do not intend to discuss
Bui, Kim Chi Co-Author, Presenting Author
No None I do intend to discuss
Busch, Michael Co-Author Yes Arthrex, Inc: Speaker I do not intend to discuss
Calkins, Kara Co-Author, Senior Author
Yes Baxter: Consultant Fresenius Kabi: Consultant
I do intend to discuss
Campbell-Washburn, Adrienne
Co-Author No None I do intend to discuss
Canterberry, Sharon Co-Author No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Caperell, Kerry Co-Author, Presenting Author
No None I do intend to discuss
Capone, Kimberly Presenting Author
Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss
Cartwright, Martina Senior Author, Presenting Author
Yes Abbott Nutrition: Consultant; Speaker's Bureau Blue Diamond Almonds: Consultant Cassiopea Inc: Employee; Stocks/Bonds Cassiopea SpA: Consultant NICO Neuro Inc: Consultant
I do intend to discuss
Casaburi, Giorgio Co-Author, Presenting Author
Yes Evolve Biosystems: Employee I do not intend to discuss
Cauvel, Teresa Co-Author Yes Neopenda PBC: Employee; Stocks/Bonds I do not intend to discuss
Cazeau, Christine Co-Author, Presenting Author
Yes Pierre Fabre: Employee I do not intend to discuss
Chen, Zhen Co-Author Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds
I do not intend to discuss
Chew, Stephanie Senior Author, Co-Author
Yes Evolve Biosystems: Employee I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Childress, Ann Presenting Author, Co-Author
Yes Aevi Genomic Medicine: Research Grant Akili Interactive Labs: Consultant; Research Grant Alcobra Pharma: Research Grant Arbor Pharmaceuticals, LLC: Consultant; Research Grant; Speaker's Bureau; Writing Support Eli Lilly: Research Grant Forest Laboratories: Research Grant Ironshore Pharmaceuticals & Development, Inc: Consultant; Research Grant; Writing Support KemPharm, Inc: Research Grant Lundbeck: Research Grant Neos Therapeutics: Consultant; Research Grant; Speaker's Bureau; Writing Support Neurovance, Inc: Consultant; Research Grant NLS Pharma: Consultant Noven: Consultant; Research Grant Otsuka America Pharmaceutical, Inc: Research Grant Pearson: Research Grant Pfizer: Consultant; Research Grant; Speaker's Bureau; Writing Support Purdue Pharma: Consultant; Research Grant Rhodes Pharmaceuticals: Consultant; Research Grant; Writing Support Shire: Consultant; Research Grant; Speaker's Bureau; Writing Support Sunovion Pharmaceuticals, Inc: Consultant; Research Grant; Writing Support Supernus Pharmaceuticals, Inc: Consultant; Research Grant Tris Pharma: Consultant; Research Grant; Speaker's Bureau; Writing Support
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Chirla, Devicharan Senior Author, Co-Author
No None I do intend to discuss
Cho, Robert Co-Author, Senior Author
Yes DePuy Synthes: Consultant; Advisory Board Ergobaby Inc: Advisory Board NuVasive: Consultant
I do not intend to discuss
Christian, Cindy Co-Author Yes Government/Law Firms: Expert Testimony I do not intend to discuss
Christian, Cindy Abstract Reviewer
Yes Government/Law firms: Medical Legal Expert Work I do not intend to discuss
Clark, Nicholas Abstract Reviewer
Yes Novartis AG: Stocks/Bonds I do not intend to discuss
Comfort, Ryan Co-Author Yes Coffective, LLC: Employee I do not intend to discuss
Crespo, Eileen Co-Author, Senior Author
Yes Stratacor: Employee I do intend to discuss
Cronyn, Drew Abstract Reviewer
No None I do intend to discuss
Cruz, Jr., Aristides Co-Author, Presenting Author, Senior Author
Yes Journal of Bone & Joint Surgery: Question Writer I do not intend to discuss
Dahl, Benny Presenting Author, Senior Author
Yes K2M: Consultant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Dampier, Carlton Co-Author Yes Epizyme: Consultant Hilton Publishing Company: Consultant Ironwood Pharmaceuticals: Consultant Merck: Consultant Micelle BioPharma: Consultant; Research Grant Modus Therapeutics: Consultant Novartis: Consultant; Research Grant Pfizer: Consultant; Research Grant
I do intend to discuss
Darbari, Deepika Co-Author, Senior Author
Yes Global Blood Therapeutics: Advisory Board Hilton Publishing Inc: Consultant Novartis: Committee Member
I do not intend to discuss
Davids, Jon Senior Author, Co-Author
Yes Orthopediatrics: Consultant I do not intend to discuss
Davidson, Kathryn Co-Author Yes Boston Children's Hospital: Employee I do not intend to discuss
DeCory, Heleen Senior Author Yes Bausch Health US, LLC: Employee I do not intend to discuss
deMayo, Richelle Abstract Reviewer
Yes Connecticut Children's: Employee I do not intend to discuss
DeSousa, Norberto Co-Author, Presenting Author
Yes Ironshore Pharmaceuticals & Development, Inc: Employee
I do not intend to discuss
Deveza, Lorenzo Co-Author, Presenting Author
Yes Lento Medical Inc: Stocks/Bonds I do not intend to discuss
Dias, Patricia Co-Author, Presenting Author
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Dodge, Ann Co-Author Yes Johnson and Johnson: Stocks/Bonds Merck: Stocks/Bonds Pfizer: Stocks/Bonds
I do not intend to discuss
Dong, Min Senior Author, Co-Author
No None I do intend to discuss
Downs, Stephen Senior Author, Co-Author
Yes Digital Health Solutions, LLC: Stocks/Bonds I do not intend to discuss
Eckert, Laurent Co-Author Yes Sanofi: Employee; Stocks/Bonds I do not intend to discuss
Einstein, Andrew Co-Author Yes Canon Medical Systems: Research Grant GE Healthcare: Consultant Roche Medical Systems: Research Grant
I do not intend to discuss
Emans, John Co-Author Yes Synthes Spine: Royalties Zimmer Biomet Spine: Consultant
I do not intend to discuss
Ernst, Kimberly Abstract Reviewer
Yes Baxter Healthcare: Consultant Fresenius Kabi: Consultant; Research Grant Nutrinia: Research Grant
I do not intend to discuss
Fairchild, Karen Co-Author, Senior Author
No None I do intend to discuss
Fairchild, Sarah Co-Author Yes Bryn Pharma: Consultant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Faraone, Stephen Co-Author Yes Akili Interactive Labs: Research Grant Arbor Pharmaceuticals, LLC: Research Grant Elsevier: Royalties Genomind: Research Grant Guilford Press: Royalties Ironshore Pharmaceuticals & Development, Inc: Research Grant Janssen Pharmaceuticals, Inc: Research Grant Otsuka America Pharmaceutical, Inc: Research Grant Oxford University Press: Royalties Shire: Research Grant Sunovion Pharmaceuticals, Inc: Research Grant Supernus Pharmaceuticals, Inc: Research Grant VAYA Pharma: Research Grant ADHD in Adults: Principal Investigator
I do not intend to discuss
Fettig, Lyle Co-Author Yes VitalTalk: Honoraria I do not intend to discuss
Figueroa, Janet Co-Author No None I do intend to discuss
Finn, Paul Co-Author No None I do intend to discuss
Fleegler, Eric Presenting Author, Co-Author
Yes North Shore Hospital: Honorarium Wolters Kluwer: Royalties Veta Health: Consultant
I do not intend to discuss
Fletcher, Nicholas Co-Author Yes Medtronic: Consultant Orthopaediatrics: Consultant Zimmer/Biomet: Speaker's Bureau
I do not intend to discuss
Flynn, John Senior Author Yes Wolters Kluwer Heath - Lippincott Williams & Wilkins: Consultant Zimmer Biomet: Consultant
I do not intend to discuss
Flynn, Joseph Abstract Reviewer
Yes Silvergate Pharmaceuticals: Consultant Ultragenyx, Inc: Data Safety Monitoring Board
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Fogel, Mark Senior Author, Presenting Author
No None I do intend to discuss
Forbes, Michael Co-Author Yes AstraZeneca: Consultant I do not intend to discuss
Frese, Steven Presenting Author, Co-Author, Senior Author
Yes Evolve Biosystems: Employee I do not intend to discuss
Friscia, Diana Co-Author Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss
Gadkari, Abhijit Senior Author Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds
I do not intend to discuss
Gair, Anne Presenting Author, Co-Author
No None I do intend to discuss
Garcia-Rodenas, Clara Co-Author Yes Nestle: Employee I do not intend to discuss
Gellasch, Patricia Co-Author, Presenting Author
Yes PEDS Online: Consultant I do not intend to discuss
Glascoe, Frances Co-Author Yes PEDS Test: Author I do not intend to discuss
Glauser, Tracy Co-Author Yes GeneSight: Consultant I do not intend to discuss
Glotzbecker, Michael Co-Author Yes Depuy Synthes: Speaker's Bureau GSSG, CSSG, HSG: Research Support Medtronic: Speaker's Bureau Nuvasive: Consultant; Speaker's Bureau Orthobullets: Consultant; Stocks/Bonds Zimmer Biomet: Speaker's Bureau
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Golombek, Sergio Abstract Reviewer
Yes Mallinckrodt: Speaker's Bureau I do not intend to discuss
Goodman, Steven Co-Author Yes Scioto Biosciences: Stocks/Bonds I do intend to discuss
GORMAN, Amanda Presenting Author
Yes Gorman and Associates: Stocks/Bonds; Sole Proprietor (LLC)
I do not intend to discuss
Govardhan, Sparsha Co-Author No None I do intend to discuss
Grant, Makenzie Presenting Author, Co-Author
Yes Pavlok: Materials Support I do intend to discuss
Green, Daniel Co-Author, Senior Author
Yes American Academy of Orthopaedic Surgery: Board/Committee Member Arthrex, Inc: Consultant; Royalties Current Opinion in Pediatrics: Editorial or Governing board; Royalties; Financial or Material support New York County Medical Society: Board/Committee Member New York State Society of Orthopedic Surgeons: Board/Committee Member Pediatric Orthopaedic Society of North America: Board/Committee Member Pega Medical: Royalties Wolters Kluwer Health - Lippincott Williams & Wilkins: Royalties; Financial or Material support
I do not intend to discuss
Greenwald, Michael Co-Author No None I do intend to discuss
Gressett Hall, Monica Co-Author No None I do intend to discuss
Grundmeier, Bob Abstract Reviewer
Yes Care Assistant: Co-Inventor I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Gubanich, Paul Senior Author, Co-Author
Yes AMSSM: Honorarium Novo Nordisk: Research Grant O'Brien & Ryan, LLP: Consultant
I do not intend to discuss
Gupta, Purnendu Co-Author Yes Depuy, A Johnson & Johnson Company: Consultant I do not intend to discuss
Gura, Kathleen Co-Author Yes B Braun: Consultant Baxter: Consultant Fresenius Kabi: Consultant Northsea Therapeutics: Consultant Otsuka Pharmaceutical Company: Consultant
I do not intend to discuss
Gutman, Colleen Co-Author, Presenting Author
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Guttman-Yassky, Emma Senior Author, Co-Author
Yes Abbvie: Consultant; Research Grant; Investigator Anacor: Consultant Asana Biosciences: Consultant Celgene: Consultant; Research Grant; Investigator Daiichi Sankyo: Consultant DBV: Consultant Dermira: Consultant; Research Grant Eli Lilly: Consultant; Investigator Galderma: Consultant; Research Grant; Investigator GlaxoSmithKline: Consultant; Investigator Glenmark: Consultant; Investigator Innovaderm: Research Grant Janssen: Research Grant Kiniksa: Consultant Kyowa: Consultant LEO Pharma: Consultant; Research Grant; Investigator Menlo Therapeutics: Consultant Novartis: Consultant Pfizer: Consultant; Research Grant; Investigator Realm: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Investigator Sanofi: Consultant; Research Grant; Investigator
I do not intend to discuss
Guzzetta, Nina Co-Author No None I do intend to discuss
Hageman, Joseph Abstract Reviewer
Yes Owlet, Inc: Consultant I do not intend to discuss
Hair, Amy Senior Author Yes Fresenius Kabi: Research Grant Prolacta Bioscience: Research Grant
I do not intend to discuss
Halpern-Felsher, Bonnie Co-Author Yes Tobacco Prevention Toolkit:Founder and Executive Director
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Hannon, Tamara Co-Author, Senior Author
Yes Eli Lilly: Consultant I do not intend to discuss
Hannon, Tamara Abstract Reviewer
Yes Eli LIlly, Inc: Consultant I do not intend to discuss
Hardatt, Dianna Presenting Author
No None I do intend to discuss
Hardesty, Christina Co-Author Yes Medtronic, Inc: Consultant Orthopediatrics: Consultant
I do not intend to discuss
Hardin, Caitlin Presenting Author
Yes IQVIA: Employee I do not intend to discuss
Harrington, Kathy Co-Author, Senior Author
No None I do intend to discuss
Harris, Matthew Co-Author No None I do intend to discuss
Hassink, Sandra Co-Author, Presenting Author
Yes Weight Watchers: Advisory Committee (Former) I do intend to discuss
Hassink, Sandra Abstract Reviewer
Yes Weight Watchers: Adolescent Cmt. Member (Former)
I do not intend to discuss
Havena-Lastarria, Daniela
Presenting Author, Co-Author
No None I do intend to discuss
Hebert, Janene Co-Author Yes Coffective, LLC: Employee I do not intend to discuss
Heffron, Melinda Co-Author No None I do intend to discuss
Heiderich, Amy Presenting Author
Yes Johnson and Johnson: Employee I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Henrick, Bethany Co-Author, Presenting Author
Yes Evolve Biosystems: Employee I do not intend to discuss
Hirshon, Jon Mark Presenting Author, Co-Author
Yes Pfizer, Inc: Consultant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Hong, Chih-ho Presenting Author, Co-Author
Yes Abbvie: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Amgen: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Bausch Health: Consultant; Speaker's Bureau Boehringer-Ingelheim: Consultant; Research Grant; Investigator Celgene: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Centocor: Research Grant; Investigator Cipher: Speaker's Bureau Cutanea: Research Grant; Investigator Dermavant: Research Grant; Investigator Eli Lilly: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Galderma: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant GlaxoSmithKline: Research Grant; Investigator Janssen: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant LEO Pharma: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant MedImmune: Research Grant; Investigator Novartis: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Speaker's Bureau; Speaker; Investigator; Consultant Roche: Consultant; Speaker's Bureau Sanofi Aventis: Consultant
I do not intend to discuss
Hsu, Daphne Abstract Reviewer
Yes Bayer: Consultant Novartis: Consultant Rocket Pharmaceuticals: Consultant
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Hu, Peng Co-Author No None I do intend to discuss
Hubbard, Dena Abstract Reviewer
Yes Abbott Nutrition: Speaker's Bureau I do not intend to discuss
Hunt, Elizabeth Co-Author, Senior Author
Yes Zoll Medical Corporation: Consultant I do not intend to discuss
Hunter, Krystal Co-Author No None I do intend to discuss
Iacobas, Ionela Co-Author No None I do intend to discuss
Incledon, Bev Co-Author, Presenting Author, Senior Author
Yes Ironshore Pharmaceuticals & Development, Inc: Employee
I do not intend to discuss
Indu, pathak Abstract Reviewer
No None I do intend to discuss
Izatt, Susan Presenting Author, Co-Author
Yes Carl Zeiss Meditech: Royalties Leica Microsystems, Inc: Royalties
I do not intend to discuss
Izuka, Byron Presenting Author
Yes Bloxr: Royalties Hely & Weber: Royalties
I do not intend to discuss
Jacobowski, Natalie Co-Author, Senior Author
No None I do intend to discuss
Jacobs, Cale Co-Author No None I do not intend to discuss
Jacobson, Elli Presenting Author
No None I do intend to discuss
Jahnke, Marla Co-Author, Senior Author
Yes Epidermolysis Bullosa Research Partners: Research Grant
I do not intend to discuss
Janow, Ginger Co-Author No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Japp, Seda Co-Author, Senior Author
Yes Bryn Pharma: Consultant I do not intend to discuss
Javidan, Yashar Co-Author No None I do intend to discuss
Jenkins, Kathy Co-Author Yes NuMed: Research Grant I do not intend to discuss
Jenkins, Kathy Senior Author Yes NuMed: Research Grant I do not intend to discuss
Johnson, Jessica Co-Author Yes Yakima Valley Farm Workers Clinic: Employee I do not intend to discuss
Johnstone, Sarah Co-Author, Senior Author
Yes Bryn Pharma: Consultant I do not intend to discuss
Jois, Sukruthi Co-Author No None I do intend to discuss
Kaelber, David Abstract Reviewer
Yes CareSource of Ohio: Board of Directors (former) I do not intend to discuss
Kaplan, Karen Abstract Reviewer
Yes Merck: Employee; Stocks/Bonds I do not intend to discuss
Karav, Sercan Co-Author Yes Evolve Biosystems: Consultant; Research Grant I do not intend to discuss
Karpen, Heidi Co-Author Yes Prolacta Bioscience: Research Grant I do not intend to discuss
Kay, Robert Co-Author, Senior Author
Yes Biomet: Stocks/Bonds Commission for Motion Lab Accreditation: Board/Committee Member Johnson & Johnson: Stocks/Bonds Journal of Pediatric Orthopaedics: Editorial or Governing board Medtronic: Stocks/Bonds Pfizer: Stocks/Bonds Zimmer: Stocks/Bonds
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Kazi, Sufyan Senior Author, Co-Author
Yes Evolve Biosystems: Employee I do not intend to discuss
Kelly, Joseph Co-Author, Presenting Author
Yes CAT Resources: Materials Support I do not intend to discuss
Kelly, Matthew Presenting Author, Co-Author
No None I do intend to discuss
Kilpatrick, Ryan Presenting Author, Co-Author
No None I do intend to discuss
Kim, Esther Presenting Author
No None I do intend to discuss
Kim, Jae Co-Author Yes Abbott Nutrition: Speaker's Bureau Alcresta: Consultant Astarte: Stocks/Bonds Ferring: Consultant Mallinckrodt: Research Grant Mead Johnson Nutrition: Speaker's Bureau Medela: Consultant Nicolette: Stocks/Bonds
I do not intend to discuss
Kinsella, Sarah Abstract Reviewer
Yes Optum: Employee I do not intend to discuss
Kirkendall, Eric Abstract Reviewer
Yes Vigilanxz: Royalties I do not intend to discuss
Klein, Bruce Co-Author, Senior Author
Yes Johnson & Johnson: Stocks/Bonds I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Klineberg, Eric Co-Author, Senior Author
Yes AOSpine: Speaker's Bureau; Fellowship Grant Depuy Synthes: Consultant K2M: Speaker's Bureau Medicrea: Consultant Stryker: Consultant
I do not intend to discuss
Knadler, Joseph Co-Author, Presenting Author
No None I do intend to discuss
Kobayashi, Ai Lan Co-Author, Senior Author
No None I do intend to discuss
Kobayashi, Roger Senior Author No None I do intend to discuss
Kramer, Dennis Abstract Reviewer
Yes Kairos Surgical: Educational support I do not intend to discuss
Kumar, Anand Senior Author, Co-Author
Yes Depuy Synthes: Consultant KLS Martin: Research Grant Polarity TE: Consultant
I do not intend to discuss
Kumari, Polly Co-Author No None I do intend to discuss
Kuo, Dennis Co-Author Yes MAXX Orthopedics: Consultant I do not intend to discuss
Labreze, Christine Presenting Author, Co-Author
Yes Pierre Fabre: Consultant I do not intend to discuss
Lawrence, J. Todd Co-Author, Senior Author
Yes Sawbones Inc: Stocks/Bonds I do not intend to discuss
Lawrence, J. Todd Abstract Reviewer
Yes Sawbones: Royalties I do not intend to discuss
Lee, Cami Co-Author No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Lee, Lois Presenting Author, Senior Author
Yes Wolters Kluwer: Royalties I do not intend to discuss
Lee, Lois Abstract Reviewer
Yes Wolters Kluwer: Author I do not intend to discuss
Lefkowitch, Jay Co-Author No None I do intend to discuss
Legge, Donna Co-Author No None I do intend to discuss
Lenke, Lawrence Co-Author Yes Broadwater: Travel Reimbursement AOSpine: Travel Reimbursement; Grant Support; Fellowship; Research Grant EOS: Grant Support; Research Grant Medtronic: Paid Consultant; Royalties; Consultant Quality Medical Publishing: Royalties Scoliosis Research Society: Travel Reimbursement; Grant Support Setting Scoliosis Straight Foundation: Grant Support; Research Grant
I do not intend to discuss
Levy, Matthew Co-Author Yes Stop the Bleeding Coalition: Chair I do not intend to discuss
Li, Su-Ting Co-Author, Senior Author
Yes Amgen: Stocks/Bonds Eli Lily: Stocks/Bonds Johnson and Johnson: Stocks/Bonds Merck: Stocks/Bonds Procter and Gamble: Stocks/Bonds
I do not intend to discuss
Lim, Foong Yeng Co-Author, Senior Author
No None I do intend to discuss
Linden, Allison Co-Author No None I do intend to discuss
Linkenbach, Jeff Co-Author Yes The Montana Institute: Stocks/Bonds I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Liu, Raymond Abstract Reviewer
Yes Orthopediatrics: Royalties I do not intend to discuss
Long, Melissa Co-Author, Presenting Author
Yes Masimo: Stocks/Bonds I do not intend to discuss
Lorenzo, Matthew Presenting Author, Co-Author
No None I do intend to discuss
Lossius, Michelle Co-Author Yes Biomarin: Research Grant I do not intend to discuss
Luhmann, Scott Co-Author, Senior Author
Yes Globus: Royalties Medtronic: Consultant; Speaker's Bureau; Royalties Orthopaediatrics: Consultant; Speaker's Bureau Stryker Spine: Consultant; Speaker's Bureau; Royalties Wishbone Medical: Consultant Wolters Kluwer: Royalties
I do not intend to discuss
Mackenzie, W.G. Stuart Co-Author Yes Stryker: Employee (Brother) I do not intend to discuss
Mackenzie, William Senior Author Yes Stryker: Employee (Son) I do not intend to discuss
Madden, Jessica Co-Author, Presenting Author
Yes Primrose Newborn Care, LLC: Owner and Founder I do not intend to discuss
Maradiaga Panayotti, Gabriela
Presenting Author, Co-Author
Yes Carolina Global Breastfeeding Institute: Speaker's Bureau
I do not intend to discuss
Marahatta, Anu Co-Author No None I do intend to discuss
Mayer, Stephanie Co-Author, Presenting Author
Yes Arthrex: Consultant Stryker: Consultant
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Mazzetti, Alessendro Presenting Author, Senior Author
Yes Cassiopea SpA: Employee; Stocks/Bonds Cosmo Pharmaceuticals: Consultant; Stocks/Bonds
I do intend to discuss
McCormick, Meghan Abstract Reviewer
No None I do intend to discuss
McElhinney, Kathryn Presenting Author, Co-Author
No None I do intend to discuss
McLoughlin, Robert Co-Author Yes Sunovion Pharmaceuticals: Employee I do not intend to discuss
Meaney-Delman, Dana Co-Author No None I do intend to discuss
Meier, Paula Co-Author Yes Medela, Inc: Research Grant I do not intend to discuss
Meisel, Erin Co-Author Yes Joint Development LLC: Stocks/Bonds I do not intend to discuss
Melamed, Isaac Presenting Author
Yes Octapharma: Research Grant I do intend to discuss
Meyer, Keith Abstract Reviewer
Yes DoctorFare, Inc: Stocks/Bonds McGraw Hill, Inc: Royalties
I do not intend to discuss
Meyer, Rina Co-Author No None I do intend to discuss
Michel, Jeremy Presenting Author
Yes American Academy of Pediatrics: Consultant Children's Hospital of Philadelphia: Employee ECRI Institute: Consultant
I do not intend to discuss
Millis, Michael Presenting Author, Co-Author
Yes Saunders/Mosby-Elsevier: Royalties; Financial or Material Support
I do not intend to discuss
Mina-Osorio, Paola Presenting Author, Co-Author
Yes Regeneron Pharmaceuticals, Inc: Employee; Stocks/Bonds
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Miranda, Holly Co-Author No None I do intend to discuss
Mistovich, R Justin Co-Author, Senior Author
Yes OrthoPediatrics: Consultant Right Mechanics: Stocks/Bonds
I do not intend to discuss
Mitchell, Ryan Co-Author Yes Evolve Biosystems Inc: Employee I do not intend to discuss
Mohamed, Ashraf Abstract Reviewer
Yes Novartis: Speaker's Bureau I do not intend to discuss
Montalbano, Amanda Co-Author, Senior Author
Yes Urgent Care Association: Speaker's Bureau I do not intend to discuss
Moorman, J. Randall Co-Author Yes AMP3D: Stocks/Bonds I do not intend to discuss
Moorthy, Ganga Presenting Author
No None I do intend to discuss
Moro, Luigi Co-Author Yes Cassiopea SpA: Employee; Stocks/Bonds Cosmo Pharmaceuticals: Employee; Stocks/Bonds
I do intend to discuss
Morris, Claudia Presenting Author, Senior Author
Yes Pfizer: Consultant PharmaNutrients, Inc: Royalties
I do not intend to discuss
Morris, Claudia Abstract Reviewer
Yes LifeTrients: Royalties Pfizer: Consultant
I do not intend to discuss
Mowitz, Meredith Abstract Reviewer
Yes Takeda-Shire: Consultant I do not intend to discuss
Myers, John Presenting Author, Co-Author
No None I do intend to discuss
Nandyal, Raja Abstract Reviewer
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Nandyal, Rajagopal Abstract Reviewer
No None I do intend to discuss
Natividad, Jane Mea M Presenting Author
Yes Nestle: Employee I do not intend to discuss
Needelman, Howard Co-Author, Presenting Author
No None I do intend to discuss
Needelman, Howard Abstract Reviewer
Yes Springer Publication: Editor; Royalties I do not intend to discuss
Newcorn, Jeffrey Co-Author, Senior Author
Yes Akili Interactive Labs: Consultant Cingulate Therapeutics: Consultant Enzymotec: Consultant; Research Grant NeuroLifeSciences Pharma: Consultant Otsuka America Pharmaceutical, Inc: Research Grant Pfizer: DSMB member Rhodes Pharmaceuticals: Consultant Shire: Consultant; Research Grant; Meeting honorarium Sunovion Pharmaceuticals, Inc: DSMB member Supernus Pharmaceuticals, Inc: Consultant; Research Grant U.S. National Football League: Consultant
I do not intend to discuss
Newland, Jason Co-Author Yes Allergan: Clinical trial Merck: Research Grant
I do not intend to discuss
Nguyen, Kim-Lien Co-Author No None I do intend to discuss
Nikolovski, Janeta Co-Author, Senior Author
Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss
Nolan, Heather Co-Author No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
O'Connor, Maeve Co-Author No None I do intend to discuss
Okonkwo, Ikechukwu Senior Author, Co-Author
No None I do intend to discuss
Olivieri, Laura Co-Author, Senior Author
No None I do intend to discuss
Olson, Andrew Presenting Author, Co-Author
No None I do intend to discuss
Olutoye, Oluyinka Abstract Reviewer
Yes Cambridge Publishers: Royalty Covidien: Research Grant Mallinckrodt: Research Grant Up-To-Date: Royalty
I do not intend to discuss
Pace, J. Lee Co-Author, Senior Author
Yes American Orthopaedic Society for Sports Medicine: Board/Committee Member Arthrex, Inc: Consultant Ceterix, Inc: Consultant Grand Rounds, Inc: Consultant Pediatric Orthopaedic Society of North America: Board/Committee Member Pediatric Research in Sports Medicine: Board/Committee Member
I do not intend to discuss
Pahys, Joshua Co-Author Yes DePuy Synthes: Consultant NuVasive: Consultant Zimmer Biomet: Consultant
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Paller, Amy S. Co-Author, Presenting Author
Yes Abbvie: Consultant; Research Grant Amgen: Consultant AnaptysBio: Research Grant; Investigator Asana: Consultant Dermavant: Consultant Dermira: Consultant Eli Lilly: Consultant; Research Grant; Investigator Forte: Consultant Galderma: Consultant; Research Grant; Investigator Incyte: Research Grant; Investigator Janssen: Research Grant; Investigator LEO Pharma: Consultant; Research Grant; Investigator Matrisys Bioscience: Consultant Menlo Therapeutics: Consultant MorphoSys/Galapagos: Consultant Novartis: Consultant; Research Grant; Investigator Pfizer: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Investigator Sanofi: Consultant; Research Grant; Investigator
I do not intend to discuss
Papillon, Stephanie Co-Author, Presenting Author
No None I do intend to discuss
Parker, Margaret Abstract Reviewer
No None I do intend to discuss
Partington, Sara Presenting Author, Co-Author
No None I do intend to discuss
Patel, Aloka Co-Author Yes Mead Johnson Nutrition: Research Grant I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Perez, Jose Abstract Reviewer
Yes Mallinkrodt: Speaker's Bureau I do not intend to discuss
Pestian, John Co-Author Yes Clarigent: Consultant GeneSight: Consultant
I do not intend to discuss
Pliszka, Steven Senior Author, Co-Author
Yes AstraZeneca: Expert Witness Ironshore Pharmaceuticals & Development, Inc: Consultant; Research Grant
I do not intend to discuss
Pohl, Erin Co-Author Yes Bryn Pharma: Consultant I do not intend to discuss
Pollack, Ari Abstract Reviewer
Yes Apple: Stocks/Bonds I do not intend to discuss
Poon, Selina Senior Author, Co-Author, Presenting Author
Yes NuVasive: Research Grant I do not intend to discuss
Prasad, Rajeev Co-Author No None I do intend to discuss
Prescilla, Randy Co-Author Yes Sanofi Genzyme: Employee; Stocks/Bonds I do not intend to discuss
Pruitt, Chris Co-Author No None I do intend to discuss
Puder, Mark Presenting Author, Senior Author
Yes Fresenius Kabi: Consultant; Patent I do not intend to discuss
Qudsi, Rameez Co-Author, Presenting Author
Yes OrthoBullets: Consultant I do not intend to discuss
Rafton, Sarah Co-Author No None I do intend to discuss
Rashid, Nazia Co-Author No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Reber, Kristina Abstract Reviewer
Yes Children's Hospital Neonatal Consortium: Board Member
I do not intend to discuss
Ren, Yaya Presenting Author, Co-Author
Yes PreeMe+You: Stocks/Bonds I do not intend to discuss
Rhodes, Jason Co-Author Yes Gait and Clinical Movement Analysis Society: Board/Committee Member Orthopediatrics: Consultant Pediatric Orthopaedic Society of North America: Board/Committee Member Pediatric Research in Sports Medicine: Board/Committee Member
I do not intend to discuss
Riccio, Anthony Co-Author, Senior Author
Yes Arthrex: Research Grant Elsevier: Royalties
I do not intend to discuss
Riley, Carley Co-Author Yes Hugo: Employee Institute for Healthcare Improvement: Consultant
I do not intend to discuss
Rochford, Laura Co-Author, Presenting Author
Yes Pavlok: Materials Support I do intend to discuss
Roiz, Ronald Co-Author Yes Medtronic: Financial or Material Support I do not intend to discuss
Rossi, Ana B. Co-Author Yes Sanofi: Employee; Stocks/Bonds I do not intend to discuss
Rumler, Sarah Abstract Reviewer
Yes Dexcom, Inc: Stocks/Bonds Hill Rom Holdings: Stocks/Bonds Integer Holdings Corp: Stocks/Bonds Intersect ENT: Stocks/Bonds
I do not intend to discuss
Rybicki, Steven Co-Author Yes Bryn Pharma: Consultant I do not intend to discuss
Rytz, Andreas Co-Author Yes Nestle: Employee I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Sallee, Randy Co-Author Yes Ironshore Pharmaceuticals, Inc: Employee P2D Bioscience: Member; Board of Directors
I do not intend to discuss
Samdani, Amer Co-Author Yes DePuy Synthes Spine: Consultant Ethicon: Consultant Globus Medical: Consultant NuVasive: Consultant; Royalties Stryker: Consultant Zimmer Biomet: Consultant; Royalties
I do not intend to discuss
Sanders, James Co-Author Yes Abbott: Stocks/Bonds Abbvie: Stocks/Bonds GE Healthcare: Stocks/Bonds GreenSun: Financial or Material Support
I do not intend to discuss
Sanfilippo, Christine Co-Author Yes Bausch Health US, LLC: Employee I do not intend to discuss
Sarwahi, Vishal Co-Author, Presenting Author
Yes Depuy Synthes: Consultant Nuvasive: Consultant Precision Spine: Consultant
I do not intend to discuss
Sawyer, Jeffrey Co-Author Yes depuy: Consultant Elsevier: Royalties (Textbook) Orthopaediatrics: Consultant Republic Spine: Consultant
I do not intend to discuss
Schechterman, Andrew Co-Author No None I do intend to discuss
Scherl, Susan Abstract Reviewer
Yes Lippincott: Royalties Wolters Kluwer: Royalties
I do not intend to discuss
Scheurer, Johannah Co-Author No None I do intend to discuss
Schreck, Paula Co-Author, Presenting Author
Yes Coffective, LLC: Consultant I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Sebsibie, Girum Presenting Author, Co-Author
No None I do intend to discuss
Sege, Robert Senior Author, Presenting Author
Yes The Montana Institute: Consultant I do not intend to discuss
Sekhar, Deepa Abstract Reviewer
Yes American Kidney Stone Management: Stocks/Bonds Higmark Foundation: Research Grant Pfizer: Research Grant
I do not intend to discuss
Shah, Nipam Co-Author Yes Pavlok: Company is providing our research study with the wearable wristbands and is also available for technical support if/when needed.
I do intend to discuss
Shah, Sona Co-Author Yes Neopenda: Employee; Stocks/Bonds I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Shah, Suken Co-Author Yes AAOS: Board/Committee Member DePuy Synthes Spine: Consultant; IP royalties DePuy Synthes Spine via Setting Scoliosis Straight Foundation: Research support Electrocore: Stocks/Bonds EOS Imaging: Consultant Globus Medical: Consultant Innovative Surgical Designs, Inc: Stocks/Bonds K2M: Stocks/Bonds; IP royalties K2M via Setting Scoliosis Straight Foundation: Research support NuVasive: Consultant NuVasive via Setting Scoliosis Straight Foundation: Research support Pediatric Orthopaedic Society of North America: Board/Committee Member Scoliosis Research Society: Board/Committee Member Setting Scoliosis Straight Foundation: Consultant; Board/Committee Member Springer: Publishing royalties; Financial or material support
I do not intend to discuss
Shames, Adam Presenting Author, Co-Author
Yes Bryn Pharma: Consultant I do not intend to discuss
Shiva, Sruti Co-Author No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Siegfried, Elaine C. Presenting Author, Co-Author
Yes Dermavant: Consultant Eli Lilly: Consultant; Research Grant; Principal investigator in clinical trials GlaxoSmithKline: Data and Safety Monitoring Board Janssen: Research Grant; Principal investigator in clinical trials. LEO Pharma: Data and Safety Monitoring Board Novan: Data and Safety Monitoring Board Pfizer: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant; Principal investigator in clinical trials Stiefel: Principal investigator in clinical trials. Verrica: Consultant; Research Grant; Principal investigator in clinical trials
I do not intend to discuss
Simpson, Eric L. Presenting Author, Co-Author
Yes Abbvie: Consultant; Research Grant Boehringer-Ingelheim: Consultant Dermavant: Consultant Eli Lilly: Consultant; Research Grant Forte Bio: Consultant Galderma: Research Grant Incyte: Consultant Kyowa Hakko Kirin: Research Grant LEO Pharma: Consultant; Research Grant Menlo Therapeutics: Consultant Merck: Research Grant Pfizer: Consultant; Research Grant Pierre Fabre Dermo Cosmetique: Consultant Regeneron Pharmaceuticals, Inc: Consultant; Research Grant Sanofi Genzyme: Consultant Valeant: Consultant
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Skaggs, David Presenting Author, Co-Author, Senior Author
Yes Biomet Spine: Consultant; Royalties; Speaker Grand Rounds: Consultant Green Sun Medical: Stocks/Bonds Growing Spine Foundation: Board/Committee Member Growing Spine Study Group: Board/Committee Member Journal of Children's Orthopedics: Editorial or governing board Medtronic: Financial or Material Support NuVasive: Consultant; Co-PI (Paid to Growing Spine Foundation); Research Grant; Research support Orthobullets: Consultant; Stocks/Bonds; Editorial or governing board Orthopedics Today: Editorial or governing board Spine Deformity: Editorial or governing board Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties; Financial or material support Zimmer: Financial or Material Support; Speaker; Consultant Zipline Medical, Inc: Stocks/Bonds
I do not intend to discuss
Slamon, Nicholas Senior Author Yes Eko: Consultant; Stocks/Bonds I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Smith, John Co-Author Yes Chest Wall and Spine Deformity Research Foundation: Board/Committee Member Children's Spine Foundation: Board of Directors DepuySynthes: Consultant Ellipse Technologies: Consultant Globus: Consultant; Royalties Missinox: Speaker's Bureau Nuvasive: Consultant Spineguard: Consultant Zimmer Biomet: Consultant
I do not intend to discuss
Soghier, Lamia Co-Author, Senior Author
Yes AAP: Royalties I do not intend to discuss
Song, Clara Abstract Reviewer
Yes Mead Johnson Nutrition: Speaker's Bureau I do not intend to discuss
Son-Hing, Jochen Co-Author Yes OrthoPediatrics: Consultant I do not intend to discuss
Soosaar, Jennifer Senior Author, Presenting Author
Yes Bryn Pharma: Consultant I do not intend to discuss
Sponseller, Paul Co-Author, Senior Author
Yes Globus: Royalties Johnson and Johnson: Research Grant; Royalties Orthopediatrics: Consultant
I do not intend to discuss
Stewart, Amanda Abstract Reviewer
Yes Boston Scientific Corporation: Employee I do not intend to discuss
Strain, Paul Presenting Author, Co-Author
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Study Group, Children's Spine
Co-Author Yes DePuy, A Johnson & Johnson Company: Research Grant NuVasive, Inc: Research Grant
I do not intend to discuss
Study Group, Growing Spine
Co-Author Yes Food and Drug Administration: Research Grant Growing Spine Foundation: Research Grant Nuvasive: Research Grant Pediatric Orthopedic Society of North America: Research Grant
I do not intend to discuss
Swanson, Jonathan Abstract Reviewer
Yes Prolacta Bioscience, Inc: Speaker's Honorarium; Travel Reimbursement
I do not intend to discuss
Sylvester, Karl Abstract Reviewer
Yes Avexegen: Consultant; Stocks/Bonds Evolve Therapeutics: Consultant HBI Solutions: Stocks/Bonds Sera Care: Research Grant
I do not intend to discuss
Telofski, Lorena Presenting Author, Co-Author
Yes Johnson & Johnson Consumer, Inc: Employee I do not intend to discuss
Thompson, George Co-Author Yes Broadwater, Inc: Consultant NuVasive: Travel Expenses OrthoPediatrics: Consultant; Stocks/Bonds Shriner's Hospital for Children: Travel Expenses, Medical Advisory Board Wolters Kluwer: Employee; Editor
I do not intend to discuss
Tolo, Vernon Presenting Author, Co-Author
Yes Journal of Bone and Joint Surgery - American: Royalties; Financial or Material Support Wolters Kluwer Health - Lippincott Williams & Wilkins: Royalties; Financial or Material Support
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Trent, Maria Senior Author Yes Church & Dwight: Consultant Hologic, Inc: Research Grant SpeeDx: Research Supplies
I do not intend to discuss
Truong, Uyen Co-Author No None I do intend to discuss
Turer, Christy Senior Author, Co-Author
Yes Health@Hand LLC: Stocks/Bonds I do not intend to discuss
Vinks, Alexander Co-Author No None I do intend to discuss
Vitale, Michael Co-Author, Senior Author
Yes Biomet: Consultant Childrens Spine Foundation: Board/Committee Member; Research support ECOP: IP royalties IPOS: Board/Committee Member NuVasive: Consultant OREF: Research support Pediatric Orthopaedic Society of North America: Board/Committee member Project for Safety in Spine Surgery: Board/Committee Member Stryker: Consultant
I do not intend to discuss
Von Bergen, Nicholas Co-Author Yes Atrility Medical: Stocks/Bonds I do not intend to discuss
Wang, Yinna Presenting Author, Co-Author
No None I do intend to discuss
Ware, Julie Co-Author, Senior Author
No None I do intend to discuss
Ware, russell Presenting Author
No None I do intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Watt, Amanda Co-Author No None I do intend to discuss
Weibel, Lisa Co-Author Yes Pierre Fabre: Consultant I do not intend to discuss
Welborn, Michelle Co-Author Yes Depuy Synthes: Consultant Pediatric Orthopedic Society of North America: Research Grant Shriners Hospital for Children: Employee; Research Grant
I do not intend to discuss
Whitehead, Kevin Co-Author, Senior Author
No None I do intend to discuss
Whitfill, Travis Co-Author Yes 410 Medical Inc: Board member I do not intend to discuss
Wilens, Timothy Presenting Author, Co-Author
Yes Alcobra Pharma: Consultant Cambridge Press: Co-Editor Elsevier: Co-Editor; Consultant Guilford Press: Editor Ironshore Pharmaceuticals & Development, Inc: Consultant; Licensing Agreement KemPharm, Inc: Consultant National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA): Consultant; Research Grant Neurovance, Inc: Consultant Otsuka America Pharmaceutical, Inc: Consultant Sunovion Pharmaceuticals, Inc: Consultant U.S. Minor/Major League Baseball: Consultant U.S. National Football League (ERM Associates): Consultant
I do not intend to discuss
Wilfley, Denise E Presenting Author, Co-Author
Yes Shire Pharmaceuticals: Consultant Sunovion Pharmaceuticals: Consultant Weight Watchers: Consultant
I do not intend to discuss
DISCLOSURE OF FINANCIAL RELATIONSHIPS All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. Individuals involved in this CME activity that are not listed did not have any relevant financial relationships to disclose and do not plan to discuss off-label/investigational uses of products. * A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Name Role Relevant Financial
Relationship
(Please indicate Yes or No)
Name of Commercial Interest(s)* Please list name(s) of entity
AND Nature of Relevant Financial Relationship(s)
(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds
excluding mutual funds, Consultant, Other - identify)
Disclosure of Off-Label (Unapproved)/Investigational Uses of Products AAP CME faculty are required to disclose to the AAP and to learners when they
plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an
unapproved or “off-label” use of an approved device or pharmaceutical.
(Do intend to discuss or Do not intend to discuss)
Revised March 2018
Williams, Conrad Co-Author, Senior Author
Yes RMS products: Consultant I do not intend to discuss
Willimon, S. Clifton Co-Author Yes Smith & Nephew Endoscopy: Consultant I do not intend to discuss
Wolfe, Heather Senior Author Yes Zoll Medical: Speaker's Bureau I do not intend to discuss
Yen, Yi-Meng Abstract Reviewer
Yes Orthopediatrics: Consultant Smith-Nephew: Consultant
I do not intend to discuss
Zebrick, Ava J. Presenting Author, Co-Author
Yes Novo Nordisk: Consultant; Speaker's Bureau I do not intend to discuss
Zertuche, Pablo Co-Author, Presenting Author
No None I do intend to discuss
Zmitrovich, April Co-Author No None I do intend to discuss